Diphtheria, tetanus, polio and pertussis vaccination

BIOLOGICAL2 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

DiphtheriaPertussisPoliomyelitisTetanus

Phase 3

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

CompletedNCT01287949

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Pertussis, Poliomyelitis +1

Start: 2011-01-31End: 2012-05-31Updated: 2017-09-11

Phase 4

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

CompletedNCT01546909

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Poliomyelitis, Tetanus

Start: 2012-02-29End: 2012-12-31Updated: 2017-09-11